| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2009: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Research Abstract |
We performed the basic research in vitro and in vivo experiments with Y-90 labeled IL-13PE Cytotoxin after agreement of material transfer with FDA CBER, and using IL-13 PE Cytotoxin that had been offered from FDA CBER Dr. Puri. Y-90 labeled IL-13PE Cytotoxin is expected the both effect to target IL-13 receptors (IL-13R) for cancer therapy and cellular damage by β-emitter, so Y-90 labeled IL-13PE Cytotoxin is expected for the new radiation anti-cancer Imunotoxin treatment.
|
